patient in the digital world
TRANSCRIPT
Patient in the digital world
How new technologies are changing the medical servicesmarket in Central and Eastern Europe
PwC 2
Key findings
The time has come to revolutionise the functioning of the healthcare systems in Central and Eastern Europe
Telemedicine is a great opportunity for all countries of our region to catch up with more advanced Western European countries and to solve many problems of today’s healthcare system (insufficient funds, queues, expensive infrastructural investments)
The growth dynamics for private healthcare expenditure in CEE countries amounts to 6% per year
As many as 60% of patients in Central and Eastern Europe are
willing to use telemedical solutions, especially teleconsulting, telemonitoring, telediagnostics and telerehabilitation
PwC
PwC
Benefitsof using telemedicine
PwC
Telemedicine has many benefits for the healthcare sector
4
2
Higher service quality, faster and better diagnosis, effective treatment plans and progress monitoring
3
5Shorter queues as a result of cost reduction and more efficient use of resources
1
Better use of working time of physicians, nurses and other specialists who are becoming increasingly scarce
4
Savings resulting from reduced capital expenditure related to infrastructure
Lower service costs both for individual visits and costs related to reduced number of visits
PwC
Drivers oftelemedicine
PwC
There are many factors indicating that the time is right for using telemedical solutions
6
2
Availability of high-quality technologies supporting the provision of telemedical services (hardware, software, communication)
3
1
Changing patient requirements in the digital world and their openness to new technologies
4
An attractive and growing market for medical services in CEE, with a large share of private expenditure and private providers
High interest on the part of private stakeholders willing to invest in and implement telemedical solutions
PwC
The market for private medical services in Central and Eastern Europe is worth nearly EUR 14 billion and continues to grow
7
• We estimate that private expenditure in our region grows at a rate of around 6% peryear, nearly double the rate of public expenditure growth
• Private expenditure related to outpatient treatment represents more than 40% of total expenditure in the segment
• The share of private expenditure is also significant in other healthcare segments (diagnostics, rehabilitation, long-term care), which positively affects development of telemedicine
1
PwC
Patients are already digital...
8
2
45%
Patient behaviours in the digital world
45% of people use or consider using mobile apps – this is much more than in the United Kingdom (32%) or in Germany (24%)
30% of patients own a smartphoneand that level should rise to 60% by 2019
70%
8
Nearly 70% of patients have access to the Internet and that level should rise to 85% by 2019
PwC
...and ready to use telemedicine
9
60% of patients in Central and Eastern
Europe are willing to use telemedicine
22
PwC
Technologies are sufficiently advanced to support the provision of telemedical services
10
Fast communication systems such as mobile devices for consultations on patient-to-physician or physician-to-physician level
Advanced medical equipment designed for the purposes of telemedicinefor example home stations with remotely connected devices such as scales, pressure measuring devices, holter monitors for ECG, remote CTG, stethoscope
Smart electronics such as wearablesfor example a watch with a heart rate monitor
Software and applicationssuch as modern software supporting diagnostic imaging, electronic patient files
Artificial intelligence toolssuch as neuron networks enabling the use of historical data to diagnose new cases
Data mining toolsto change available information into data which can be used in treatment
33
PwC
There are many stakeholders in the market who are willing to invest in telemedicine
11
4
Benefits from implementingtelemedicine
• Reaching new patient groups from smaller towns
• Lower costs of providing services
• Reducing waiting room occupancy
• Service expansion in online channels
• Ensuring fast access to specialists
• Intensifying cooperationand education within an organisation
• Extending the current product portfolio
• Reaching new patient groups from small towns
• Lower costs of providing services
• Service expansion in online channels
• Ensuring fast access to specialists
• Increasing access to potential patients
• Building own brand imageand recognition
• More effective working time planning
• Having a platform in place which provides patients with free access to medical information
• Possibility to analyse the effectiveness of manufactured drugs
• Building relationswith patients taking drugs to treat specific conditions
• Strong analytical supportin clinical research
• Developing new business models (e.g. pharmacies with telemedical services)
• Entry into a new market segment and use of key skills such as construction of devices, software development
• Use of artificial intelligence tools or data mining
• Ensuring the ability to collect and analyse medical data and providing solutions
Clinic networks offering medi-care
packages
Insurers Individual physicians
Pharmaceutical and consumer
goods companies
Technology companies
4
PwC
Recommendations
PwC
We suggest the following recommendations for entities operating in the healthcare sector
13
2
Enhancing brand image and recognition 3
5
6
Development of methods to understand the patient and optimisation of patient experience
1
Building a modern organisation for patient acquisition
4
Designing and implementing a new operating model
Collaboration with entities from the sector of consumer goods and services
Building a proactive, as opposed of reactive, approach to healthcare
7 Collecting data and using it in medical processes
Thank you
© 2016 PwC Polska Sp. z o.o. All rights reserved. PwC refers to the PwC Polska Sp. z o.o., member
firm, and may sometimes refer to the PwC network. Each member firm is a separate legal entity.
Szymon PiatkowskiDeputy DirectorHead of CEE Healthcare Advisory
+48 519 507 781
Mariusz Ignatowicz PartnerLeader of CEE Healthcare and Pharma
+48 502 184 795